Find similar content

Source channel @githubtrending · Post #15239 · Oct 21

#python#artificial_intelligence#cloud_ml#computer_systems#courseware#deep_learning#edge_machine_learning#embedded_ml#machine_learning#machine_learning_systems#mobile_ml#textbook#tinyml You can learn how to build real-world AI systems from start to finish with an open-source textbook originally from Harvard University. It teaches you not just how to train AI models but how to design scalable systems, manage data pipelines, deploy models in production, monitor them continuously, and optimize for devices like phones or IoT gadgets. This helps you become an engineer who can create efficient, reliable, and sustainable AI systems that work well in practice. The book offers hands-on labs, community support, and free online access, making it easier to gain practical skills in machine learning systems engineering. https://github.com/harvard-edge/cs249r_book

Hashtags

#python #artificial_intelligence #cloud_ml #computer_systems #courseware #deep_learning #edge_machine_learning #embedded_ml #machine_learning #machine_learning_systems #mobile_ml #textbook #tinyml

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment